AbCellera Biologics Inc. ABCL Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by AbCellera Biologics Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The official record: AbCellera Biologics Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →
Ask your AI about AbCellera Biologics Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is AbCellera Biologics Inc.'s total current assets?
- AbCellera Biologics Inc. (ABCL) reported total current assets of $664.6M in Q1 2026.
- How has AbCellera Biologics Inc.'s total current assets changed year-over-year?
- AbCellera Biologics Inc.'s total current assets decreased by 13.1% year-over-year, from $764.98M to $664.6M.
- What is the long-term trend for AbCellera Biologics Inc.'s total current assets?
- Over 5 years (2020 to 2025), AbCellera Biologics Inc.'s total current assets has grown at a -2.2% compound annual growth rate (CAGR), from $813.33M to $728.23M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.